Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment fo… (NCT06582693) | Clinical Trial Compass
RecruitingNot Applicable
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
United States3,200 participantsStarted 2024-09-06
Plain-language summary
The goal of this clinical trial is to compare the reach and effectiveness of the Refer2Quit intervention for increasing tobacco use treatment and quit rates among household members who smoke versus a treatment as usual group. This clinical trial also aims to study household member and pediatric patient characteristics that are associated with reach and effectiveness of Refer2Quit.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Adult Intervention Subject Inclusion Criteria
* Males or females ages ≥18 years in age
* Self-identify as a current combustible tobacco user
* Have a valid cell phone number
Child Intervention Subject Inclusion Criteria
* Must be a CHOP patient
Adult Intervention Subject Exclusion Criteria
* \<18 years in age.
* Indicates no combustible tobacco smoking
Child Intervention Subject Exclusion Criteria
* Not a CHOP patient
Adult Control Subject Inclusion Criteria
* Males or females ages ≥18 years in age
* Self-identify as a current combustible tobacco user
* Have a valid cell phone number
Child Control Subject Inclusion Criteria
* Must be a CHOP patient
Adult Control Subject Exclusion Criteria
* \<18 years in age.
* Indicates no combustible tobacco smoking
Child Control Subject Exclusion Criteria
* Not a CHOP patient
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
The proportion of adult participants who engage in any evidence-based tobacco use treatments